Double maintains 1 strategies that include YMAB - Y-mAbs Therapeutics, Inc.
Current Value
$4.311 Year Return
Current Value
$4.311 Year Return
Yahoo
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Finnhub
Radiopharmaceutical R&D Update May 28, 2025 ...
Finnhub
Presentation Operator MessageOperator Good morning. Welcome to Y-mAbs Therapeutics virtual Radiopharmaceutical R&D update webcast and conference call. As a reminder, today's conference will be...
Yahoo
Company’s Part A data readout from first-in-human Phase 1 Trial 1001 in patients with recurrent or refractory metastatic solid tumors known to express GD2, validates GD2-SADA as safe, tolerable and able to achieve targeted in vivo conjugation of 177Lu-DOTAIncreased tumor retention and total tumor uptake anticipated by using optimized universal RadiohaptenCompany plans to initiate a Trial 1001 Bridge study (Part 2A) with optimized Radiohapten, “Proteus”, in 1H 2026 with data readout in 2H 2026; P
Yahoo
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) has presented the early-stage clinical data from its GD2-SADA PRIT trial at the Advances in Neuroblastoma Research (ANR) Meeting in Washington, D.C. The presentation marks a significant update in its experimental pipeline. The trial-in-progress poster contained findings from Trial 1001, a Phase 1 study assessing GD2-SADA Pretargeted Radioimmunotherapy using 177Lu-DOTA in […]
Yahoo
PRINCETON, N.J., May 26, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, today announced the presentation of GD2-SADA in recurrent or refractory metastatic solid tumors known to express GD2 in a trial in progress poster at the Advances in Neuroblastoma Research
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ARWR | 52.52% | $2.33B | -32.59% | 0.00% |
| OCUL | 50.41% | $1.51B | +41.41% | 0.00% |
| CRSP | 48.56% | $4.46B | -4.14% | 0.00% |
| FATE | 47.30% | $128.39M | -64.56% | 0.00% |
| IMNM | 46.94% | $750.92M | -28.80% | 0.00% |
| RXRX | 46.30% | $2.12B | -29.12% | 0.00% |
| NTLA | 45.19% | $1.11B | -53.25% | 0.00% |
| BEAM | 44.44% | $2.00B | -15.33% | 0.00% |
| DNLI | 42.45% | $2.16B | -30.05% | 0.00% |
| OVID | 42.25% | $23.50M | -56.03% | 0.00% |
| SYRE | 41.94% | $935.48M | -39.83% | 0.00% |
| IMVT | 41.75% | $2.87B | -35.84% | 0.00% |
| CATX | 41.56% | $251.63M | -68.47% | 0.00% |
| CGEM | 41.54% | $457.95M | -53.75% | 0.00% |
| RNA | 41.04% | $3.54B | -21.10% | 0.00% |
| IDYA | 40.93% | $1.92B | -34.15% | 0.00% |
| COGT | 40.92% | $843.67M | -11.36% | 0.00% |
| CRBU | 40.69% | $127.42M | -14.38% | 0.00% |
| EYPT | 40.55% | $664.72M | +12.07% | 0.00% |
| GCI | 40.24% | $553.53M | -21.58% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BTCT | -12.07% | $25.56M | +61.14% | 0.00% |
| ED | -11.27% | $36.00B | +12.64% | 3.34% |
| CBOE | -9.24% | $24.23B | +35.36% | 1.09% |
| PSQH | -9.24% | $98.82M | -36.55% | 0.00% |
| DFDV | -9.02% | $300.56M | +2,130.16% | 0.00% |
| AQB | -8.08% | $2.96M | -53.35% | 0.00% |
| NEUE | -5.55% | $61.24M | +29.92% | 0.00% |
| CCEC | -5.25% | $1.02B | +3.91% | 2.58% |
| DUK | -4.41% | $90.99B | +17.25% | 3.56% |
| HUSA | -4.30% | $19.66M | -19.53% | 0.00% |
| EXC | -4.25% | $43.33B | +23.58% | 3.62% |
| CME | -3.51% | $99.39B | +40.68% | 3.86% |
| AEP | -3.49% | $55.16B | +17.93% | 3.54% |
| MO | -3.42% | $99.67B | +28.77% | 6.90% |
| LITB | -3.23% | $21.24M | -78.57% | 0.00% |
| VHC | -2.37% | $48.19M | +108.24% | 0.00% |
| VRCA | -2.24% | $59.96M | -91.36% | 0.00% |
| AWK | -2.07% | $27.36B | +9.65% | 2.21% |
| TME | -1.94% | $13.41B | +28.31% | 0.94% |
| IMDX | -1.92% | $86.94M | -0.65% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AMT | 0.02% | $104.32B | +14.40% | 3.00% |
| LTM | -0.03% | $12.63B | -95.46% | 2.42% |
| EQT | 0.03% | $33.61B | +51.57% | 1.12% |
| TU | -0.07% | $24.75B | +7.77% | 7.12% |
| PDD | -0.14% | $144.39B | -24.30% | 0.00% |
| ASPS | -0.15% | $108.30M | -4.13% | 0.00% |
| COR | 0.22% | $56.44B | +30.86% | 0.74% |
| OXBR | 0.25% | $16.90M | +1.79% | 0.00% |
| MOH | 0.28% | $12.95B | -19.36% | 0.00% |
| SO | -0.28% | $100.18B | +17.28% | 3.18% |
| EQNR | -0.31% | $70.85B | -6.80% | 5.49% |
| STNG | -0.34% | $2.14B | -48.70% | 3.80% |
| ZCMD | -0.39% | $29.55M | -8.59% | 0.00% |
| K | 0.43% | $27.76B | +41.17% | 2.85% |
| LMT | 0.46% | $108.37B | -0.75% | 2.81% |
| CCRN | -0.52% | $429.13M | -3.89% | 0.00% |
| CNC | -0.56% | $16.81B | -49.40% | 0.00% |
| NG | 0.62% | $1.82B | +29.48% | 0.00% |
| UUU | -0.62% | $7.17M | +101.30% | 0.00% |
| PRPO | -0.63% | $17.08M | +125.94% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -31.60% | $164.54M | 0.85% |
| BTAL | -31.02% | $296.22M | 1.43% |
| TAIL | -28.47% | $99.63M | 0.59% |
| SHYM | -12.10% | $357.13M | 0.35% |
| IVOL | -10.82% | $347.03M | 1.02% |
| UGA | -9.61% | $72.33M | 0.97% |
| CTA | -9.19% | $1.06B | 0.76% |
| BSMW | -9.16% | $107.45M | 0.18% |
| PSQA | -7.36% | $35.44M | 0.2% |
| STPZ | -7.15% | $450.47M | 0.2% |
| FTSD | -7.11% | $231.81M | 0.25% |
| USDU | -6.52% | $162.43M | 0.5% |
| DBE | -6.17% | $52.20M | 0.77% |
| TPMN | -6.07% | $30.70M | 0.65% |
| UNG | -5.71% | $360.54M | 1.06% |
| UUP | -5.13% | $201.63M | 0.77% |
| BNO | -4.22% | $103.79M | 1% |
| USO | -3.93% | $1.13B | 0.6% |
| CANE | -3.47% | $10.37M | 0.29% |
| XONE | -3.46% | $625.28M | 0.03% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 55.84% | $44.57M | 0.5% |
| XBI | 53.02% | $4.82B | 0.35% |
| ARKG | 51.11% | $1.02B | 0.75% |
| IBB | 48.00% | $5.26B | 0.45% |
| PTH | 47.48% | $100.85M | 0.6% |
| IWC | 46.80% | $818.14M | 0.6% |
| PBE | 46.58% | $223.19M | 0.58% |
| IWO | 46.49% | $11.60B | 0.24% |
| KJUL | 45.84% | $119.50M | 0.79% |
| IWM | 45.09% | $63.72B | 0.19% |
| VTWO | 44.91% | $12.52B | 0.07% |
| PINK | 44.35% | $130.57M | 0.5% |
| XPH | 43.84% | $147.96M | 0.35% |
| KJAN | 43.79% | $287.30M | 0.79% |
| KOMP | 43.74% | $2.29B | 0.2% |
| GSSC | 43.69% | $561.54M | 0.2% |
| SCHA | 42.92% | $17.26B | 0.04% |
| ISCG | 42.78% | $681.20M | 0.06% |
| PRFZ | 42.77% | $2.36B | 0.34% |
| CPRJ | 42.69% | $48.26M | 0.69% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GBIL | 0.01% | $6.37B | 0.12% |
| DFNM | 0.03% | $1.57B | 0.17% |
| VGIT | 0.05% | $31.89B | 0.04% |
| GSG | 0.06% | $959.40M | 0.75% |
| IBTH | 0.08% | $1.62B | 0.07% |
| IBTJ | 0.13% | $688.19M | 0.07% |
| TYA | 0.14% | $152.69M | 0.15% |
| TBLL | -0.31% | $2.13B | 0.08% |
| IEI | -0.33% | $15.48B | 0.15% |
| IBTK | 0.34% | $448.89M | 0.07% |
| IBTM | -0.37% | $316.49M | 0.07% |
| FLGV | 0.38% | $1.03B | 0.09% |
| SPTI | 0.39% | $8.82B | 0.03% |
| SPIP | 0.40% | $969.51M | 0.12% |
| SCHR | 0.41% | $10.92B | 0.03% |
| ICLO | 0.47% | $316.83M | 0.19% |
| SHY | 0.59% | $23.83B | 0.15% |
| USCI | 0.64% | $241.75M | 1.07% |
| IBTI | -0.66% | $1.06B | 0.07% |
| SPSK | -0.68% | $321.02M | 0.5% |
